372 related articles for article (PubMed ID: 24044645)
1. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles as delivery systems for Gambogenic acid.
Huang X; Chen YJ; Peng DY; Li QL; Wang XS; Wang DL; Chen WD
Colloids Surf B Biointerfaces; 2013 Feb; 102():391-7. PubMed ID: 23010123
[TBL] [Abstract][Full Text] [Related]
3. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU.
He RX; Ye X; Li R; Chen W; Ge T; Huang TQ; Nie XJ; Chen HJ; Peng DY; Chen WD
J Liposome Res; 2017 Jun; 27(2):161-170. PubMed ID: 27184460
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-modified nonionic surfactant vesicles for gambogenic acid targeting: Preparation, characterization, and in vitro and in vivo evaluation.
Lin TY; Chang JL; Xun Y; Zhao Y; Peng W; Yang W; Ding BJ; Chen WD
Kaohsiung J Med Sci; 2020 May; 36(5):344-353. PubMed ID: 32293112
[TBL] [Abstract][Full Text] [Related]
5. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
7. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
8. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
[TBL] [Abstract][Full Text] [Related]
9. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
10. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
11. Niosomes as carriers of radiopaque contrast agents for X-ray imaging.
Muller D; Foulon M; Bonnemain B; Vandamme TF
J Microencapsul; 2000; 17(2):227-43. PubMed ID: 10738698
[TBL] [Abstract][Full Text] [Related]
12. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.
Huang Y; Chen J; Chen X; Gao J; Liang W
J Mater Sci Mater Med; 2008 Feb; 19(2):607-14. PubMed ID: 17619962
[TBL] [Abstract][Full Text] [Related]
13. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
Mokhtar M; Sammour OA; Hammad MA; Megrab NA
Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
[TBL] [Abstract][Full Text] [Related]
14. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
15. Collagen loaded nano-sized surfactant based dispersion for topical application: formulation development, characterization and safety study.
Ahmad I; Akhter S; Ahmad MZ; Shamim M; Rizvi MA; Khar RK; Ahmad FJ
Pharm Dev Technol; 2014 Jun; 19(4):460-7. PubMed ID: 23675949
[TBL] [Abstract][Full Text] [Related]
16. Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells.
Amiri B; Ahmadvand H; Farhadi A; Najmafshar A; Chiani M; Norouzian D
Drug Dev Ind Pharm; 2018 Aug; 44(8):1371-1376. PubMed ID: 29532687
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
18. Design and characterization of ofloxacin niosomes.
Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S
Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
Pardakhty A; Varshosaz J; Rouholamini A
Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
